These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15949381

  • 1. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):753-9. PubMed ID: 15949381
    [Abstract] [Full Text] [Related]

  • 2. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):458-63. PubMed ID: 15854551
    [Abstract] [Full Text] [Related]

  • 3. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 4. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA).
    Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, Grigoletto F, ILSA Working Group.
    Nephrol Dial Transplant; 2005 Jan 13; 20(1):114-23. PubMed ID: 15572387
    [Abstract] [Full Text] [Related]

  • 5. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 13; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May 13; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 May 13; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT, Chan JC, Chow CC, Yeung VT, Chan WB, So WY, Ma RC, Ozaki R, Cockram CS.
    Acta Diabetol; 2003 Jun 13; 40(2):80-4. PubMed ID: 12861405
    [Abstract] [Full Text] [Related]

  • 9. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ, Ceballos M, Grupo de tabajo sobre Calidad de la Hemodiálisis en Andalucía.
    Nefrologia; 2004 Jun 13; 24(2):149-57. PubMed ID: 15219090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
    Healy H, Reith D, Morgan C, Clague A, Westhuyzen J.
    Ann Clin Lab Sci; 2000 Jul 13; 30(3):295-304. PubMed ID: 10945571
    [Abstract] [Full Text] [Related]

  • 18. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P, Kozłowski M, Grajewska M, Kurowski R, Stefańska A, Odrowaź-Sypniewska G, Serafin Z, Lasek W, Nartowicz E, Kubica J, Manitius J.
    Pol Merkur Lekarski; 2006 Aug 13; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [Abstract] [Full Text] [Related]

  • 19. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 13; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 20. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ.
    J Am Soc Nephrol; 2005 Jun 13; 16(6):1803-10. PubMed ID: 15857925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.